Intensive care
An intensive care unit (ICU) treats the most critically ill patients. The treatment period is often long, and for every hospitalized day, the risk of infection caused by medical devices increases. Why risk that the most critically ill and vulnerable patients become even sicker?

Proprietary BIP portfolio discontinued
Following a strategic review late 2023, it was decided to discontinue Bactiguard’s proprietary BIP product portfolio. The Bactiguard coated Foley catheters are exclusively offered by license partner BD (Becton, Dickinson & Company) globally, apart from China where the Foley catheters are exclusively offered by license partner Well Lead.
For further information about the discontinuation, please contact us here.
Central venous catheter (CVC) that prevents infection
BIP CVC is a central venous catheter with Bactiguard’s infection prevention technology. Fewer bacteria attach to the catheter surface, which reduces the risk of catheter associated infection.
Endotracheal tube with double protection
BIP ETT Evac is the only tube on the market that combines the subglottic secretion drainage with the ability of the Bactiguard coating to reduce microbial adhesion.
Endotracheal tube that prevents infection
BIP ETT is an endotracheal tube with Bactiguard’s infection prevention technology. Fewer bacteria attach to the tube surface, which reduces the risk of infection.
Prevents catheter-related urinary tract infection
BIP Foley Catheter is an indwelling urinary catheter with Bactiguard coating. Less bacteria adhere to the catheter surface, which reduces the risk of catheter related urinary tract infection.